Review: The Biochemical Basis of Non-Steroidal Anti-Inflammatory Drug-Induced Damage to the Gastrointestinal Tract: A Review and a Hypothesis

References

• Barrier C H, Hirschowitz B I. Current controversies in rheumatology. Controversies and management of non-steroidal anti-inflammatory drug induced side effects on upper gastrointestinal tract. Arthritis Rheum 1989; 32: 926–9
   PubMed Web of Science ®Google Scholar
• Roth S H, Bennett R E. Non-steroidal anti-inflammatory drug gastropathy recognition and response. Arch Intern Med 1987; 147: 2093–100
   PubMedGoogle Scholar
• Tympner F. Gastroscopic findings after therapy with nonsteroidal anti-inflammatory drugs. J Rheumatol 1981; 40: 179–81
   Google Scholar
• Graham D Y, Agrawal N M, Roth S H. Prevention of NSAID-induced gastric ulcer with misoprostol: multicenter double blind, placebo-controlled trial. Lancet 1988; 2: 1277–80
   PubMed Web of Science ®Google Scholar
• Quinn C M, Bjarnason I, Price A B. Gastritis in patients on non-steroidal anti-inflammatory drugs. Histopathology 1993; 23: 341–8
   PubMedGoogle Scholar
• Morgan R. Non-aspirin nonsteroidal anti-inflammatory drugs and active gastroduodenal ulceration in the elderly. Br J Rheumatol 1987; 26: 158–9
   PubMedGoogle Scholar
• Lakari E N, Lacey Smith J, Lidsky M D, Graham D Y. Gastroduodenal damage and dyspeptic symptoms in arthritis patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol 1987; 82: 1153–8
   PubMed Web of Science ®Google Scholar
• Graham D Y, Lidsky M D, Cox A M, Evans D J, Evans D G, Alpert L, et al. Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection. Gastroenterology 1991; 100: 1653–7
   PubMed Web of Science ®Google Scholar
• Morris A D, Holt S D, Silvoso G R, Hewitt S, Tatum W, Grandiowe J, et al. The effect of anti-inflammatory drug administration in patients with rheumatoid arthritis. An endoscopic assessment. Scand J Gastroenterol 1981; 16(Suppl 67)131–5
   Google Scholar
• Collins A J, Davies J, Dixon A SJ. Contrasting presentation and findings between patients with rheumatic complaints taking non-steroidal anti-inflammatory drugs and a general population referred to endoscopy. Br J Rheumatol 1986; 25: 50–3
   PubMedGoogle Scholar
• Walt R. Drug therapy: misoprostol for the treatment of peptic ulcer and antiinflammatory drug-induced gastroduodenal ulceration. N Engl J Med 1992; 327: 1575–80
   PubMed Web of Science ®Google Scholar
• Bardhan K D, Bjarnason I, Scott D L, Griffin W M, Fenn G C, Shields M J, et al. The prevention and healing of acute NSAID-associated gastroduodenal mucosal damage by misoprostol. Br J Rheumatol 1993; 32: 990–5
   PubMedGoogle Scholar
• Faulkner G, Prichard P, Somerville K, Langman M JS. Aspirin and bleeding peptic ulcer in the elderly. Br Med J 1988; 297: 1311–3
   PubMed Web of Science ®Google Scholar
• Armstrong C P, Blower A L. Nonsteroidal anti-inflammatory drugs and life threatening complications of peptic ulcer disease. Gut 1987; 28: 527–32
   PubMed Web of Science ®Google Scholar
• Fries J F, Miller S R, Spitz P W, Williams C A, Hubert H B, Bloch D A. Toward an epidemiology of gastropathy associated with non-steroidal anti-inflammatory drug use. Gastroenterology 1989; 96: 647–55, Suppl
   PubMed Web of Science ®Google Scholar
• Griffin M R, Ray W AY, Schaffner W. Non-steroidal antiinflammatory drug use and death from peptic ulceration. Ann Intern Med 1988; 109: 359–63
   PubMed Web of Science ®Google Scholar
• Levy M, Miller D R, Kaufman D W, Siskind V, Schwingll P, Rosenberg L, et al. Major upper gastrointestinal tract bleeding: relation to the use of aspirin and other non narcotic analgesics. Arch Int Med 1988; 148: 281–285
   PubMedGoogle Scholar
• Knill-Jones R, Drummond M, Kohli H, Davies L. Economic evaluation of gastric ulcer prophylaxis in patients with arthritis receiving non-steroidal anti-inflammatory drugs. Postgrad Med J 1990; 66: 639–46
   PubMed Web of Science ®Google Scholar
• Cockel R. NSAIDs—should every prescription carry a government health warning?. Gut 1987; 28: 515–8
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Williams P, So A, Zanelli G, Levi A J, Gumpel M J, et al. Intestinal permeability and inflammation in rheumatoid arthritis; effects of non-steroidal anti-inflammatory drugs. Lancet 1984; 2: 1171–4
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Williams P, Smethurst P, Peters T J, Levi A J. The effect of NSAIDs and prostaglandins on the permeability of the human small intestine. Gut 1986; 27: 1292–7
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Peters T J. Helping the mucosa make sense of macromolecules. Gut 1987; 28: 1057–61
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Zanelli G, Prouse P, Smethurst P, Levi S, Gumpel M J, et al. Blood and protein loss via small intestinal inflammation induced by nonsteroidal anti-inflammatory drugs. Lancet 1987; 2: 711–4
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Price A B, Zanelli G, Smethurst P, Burk M, Gumpel M J, et al. Clinico-pathological features of NSAID induced small intestinal strictures. Gastroenterology 1988; 94: 1070–4
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Hayllar J, Macpherson A J, Russell A S. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine. Gastroenterology 1993; 104: 1932–7
   Web of Science ®Google Scholar
• Lang J, Price A B, Levi A J, Burk M, Gumpel J M, Bjarnason I. Diaphragm disease: the pathology of non-steroidal antiinflammatory drug induced small intestinal strictures. J Clin Pathol 1988; 41: 516–26
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Zanelli G, Smith T, Prouse P, Williams P, Delacey G, et al. Nonsteroidal antiinflammatory drug induced intestinal inflammation in humans. Gastroenterology 1987; 93: 480–9
   PubMed Web of Science ®Google Scholar
• Allison M C, Howatson A G, Torrance C J, Lee F D, Russell R I. Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. N Engl J Med 1992; 327: 749–54
   PubMed Web of Science ®Google Scholar
• Morris A J, Wasson L A, Mackenzie J F. Small bowel enteroscopy in undiagnosed gastrointestinal blood loss. Gut 1992; 33: 887–9
   PubMed Web of Science ®Google Scholar
• Rooney P J, Jenkins R T, Smith K M, Coates G. 111-Indium-labelled polymorphonuclear scans in rheumatoid arthritis— an important clinical cause of positive results. Br J Rheumatol 1986; 15: 167–70
   Google Scholar
• Segal A W, Isenberg D A, Hajirousow V, Tolfree S, Clark J, Snaith M L. Preliminary evidence for gut involvement in the pathogenesis of rheumatoid arthritis?. Br J Rheumatol 1986; 25: 162–6
   PubMedGoogle Scholar
• Huber T, Ruchti C, Halter F. Nonsteroidal antiinflammatory drug-induced colonic strictures: a case report. Gastroenterology 1992; 100: 1119–22
   Web of Science ®Google Scholar
• Johnson F. Recurrent small bowel obstruction with piroxicam. Br J Surg 1987; 74: 654
   Google Scholar
• Sukumar L. Recurrent small bowel obstruction with piroxicam. Br J Surg 1987; 74: 186
   PubMedGoogle Scholar
• Phillips M S, Fehilly B, Stewart S, Dronfild W M. Enteritis and colitis associated with mefenamic acid. Br Med J 1983; 287: 1626–7
   PubMedGoogle Scholar
• Rampton D S, Trapping P J. Enteritis and colitis associated with mefenamic acid. Br Med J 1983; 287: 1627
   Google Scholar
• Williams R, Glazier G. Enteritis and colitis associated with mefenamic acid. Br Med J 1983; 287: 1627
   Google Scholar
• Tanner A R, Raghunat H. Colonic inflammation and NSAID administration. Digestion 1988; 41: 116–20
   PubMed Web of Science ®Google Scholar
• Ravi S, Keat A C, Keat E CB. Colitis caused by NSAID. Postgrad Med J 1986; 62: 773–6
   PubMed Web of Science ®Google Scholar
• Edwards A L, Heagerty A M, Bing R F. Enteritis and colitis associated with mefenamic acid. Br Med J 1983; 287: 1627
   Google Scholar
• Coutrot S, Roland D, Barbier J, Marcq P VD, Alcalay M, Matuchansky C. Acute perforation of colonic diverticula associated with short term indomethacin. Lancet 1978; 2: 1055–6
   PubMed Web of Science ®Google Scholar
• Campbell K L, De Baux A C. Non-steroidal anti-inflammatory drugs and appendicitis in patients aged over 50 years. Br J Surg 1992; 79: 967–8
   PubMedGoogle Scholar
• Campbell K, Steele R JC. Non-steroidal anti-inflammatory drugs and complicated diverticular disease: a case control study. Br J Surg 1991; 78: 190–1
   PubMedGoogle Scholar
• Kaufman H J, Taubin H L. NSAID activate quiescent inflammatory bowel disease. Ann Intern Med 1987; 107: 513–6
   PubMed Web of Science ®Google Scholar
• Rampton D S, McNeil M I, Sarner M. Analgesic ingestion and other factors preceding relapse in ulcerative colitis. Gut 1983; 24: 187–9
   PubMed Web of Science ®Google Scholar
• Rampton D S, Sladen G E. Relapse of ulcerative proctocolitis during treatment with NSAID. Postgrad Med J 1981; 57: 297–9
   PubMed Web of Science ®Google Scholar
• Wilson R G, Smith A N, Macintyre I MC. Complications of diverticular disease and nonsteroidal anti-inflammatory drugs: a prospective study. Br J Surg 1990; 77: 1103–4
   PubMed Web of Science ®Google Scholar
• Finkelstein J A, Jamieson C G. An association between anti-inflammatory medication and internal pelvic fistulas. Dis Colon Rectum 1987; 30: 168–170
   PubMed Web of Science ®Google Scholar
• Whittle B JR. Protective mechanisms of the gastric mucosa. The stomach. Edinburgh: Churchill Livingstone, S Gustsavsson, D Kumar, D Y Graham, 1992; 81–101
   Google Scholar
• Wallace J L. Non-steroidal anti-inflammatory drug gastropathy and cytoprotection: pathogenesis and mechanisms re-examined. Scand J Gastroenterol 1992; 27(Suppl 192)3–8
   Web of Science ®Google Scholar
• Brodie D A, Cook P G, Bauer B J, Dagleg E. Indomethacin-induced intestinal lesions in the rat. Toxicol Appl Pharmacol 1970; 17: 615–24
   PubMed Web of Science ®Google Scholar
• Brune K, Dietzel K, Nurnberg B, Schneider H-Th. Recent insight into the mechanism of gastrointestinal tract ulceration. Scand J Rheumatol 1987, Suppl 65: 135–40
   PubMedGoogle Scholar
• Del Soldato P, Foschi D, Benoni G GPV. Early and late phases in the formation by anti-inflammatory drugs of intestinal lesions in the rat. Side effects of antiinflammatory drugs, K D Rainsford, G P Velo. MTP Press, Lancaster 1987; 67–81
   Google Scholar
• Fang W-F, Broughton A, Jacobson E D. Indomethacin-induced intestinal inflammation. Dig Dis Sci 1977; 22: 187–90
   Google Scholar
• Kent T H, Cardeli R M, Stanler F U. Small intestinal ulcers and intestinal flora in rats given indomethacin. Am J Pathol 1969; 54: 237–45
   PubMed Web of Science ®Google Scholar
• Melrange R, Moore G, Blower P R, Coates M E, Ward F W, Ronaasen V. A comparison of indomethacin with ibuprofen on gastrointestinal mucosal integrity in conventional and germ free rats. Aliment Pharmacol Ther 1992; 6: 67–77
   PubMed Web of Science ®Google Scholar
• Rainsford K D. Mucosal lesions induced in the rat intestinal tract by the anti-inflammatory drug, Wy-41,770, a weak inhibitor of prostaglandin synthesis, contrasted with those from the potent prostaglandin inhibitor, indomethacin. Toxicol Pathol 1988; 16: 366–75
   PubMed Web of Science ®Google Scholar
• Robert A TA. Resistance of germ free rats to indomethacin-induced intestinal lesions. Prostaglandins 1977; 14: 331–41
   Google Scholar
• Roberts A. Cytoprotection by prostaglandins. Gastroenterology 1975; 77: 761–7
   Google Scholar
• Satoh H, Guth P H, Grossman M I. Role of bacteria in gastric ulceration produced by indomethacin in the rat: cytoprotective action of antibiotics. Gastroenterology 1983; 84: 483–9
   PubMed Web of Science ®Google Scholar
• Rainsford K D. The biochemical pathology of aspirin induced gastric damage. Agents Actions 1975; 5: 326–44
   PubMedGoogle Scholar
• Redfern J S, Feldman M. Role of prostaglandins in preventing gastrointestinal ulceration: induction of ulcers by antibodies to prostaglandins. Gastroenterology 1989; 96: 595–605
   Web of Science ®Google Scholar
• Ligumski M, Golanska E M, Hansen D G, Kauffman G L. Aspirin can inhibit gastric mucosal cyclo-oxygenase without causing lesions in the rat. Gastroenterology 1983; 84: 756–61
   PubMed Web of Science ®Google Scholar
• Levine R A, Petokas S, Nandi J, Enthoven D. Effects of nonsteroidal anti-inflammatory drugs on gastrointestinal injury and prostanoid generation in healthy volunteers. Dig Dis Sci 1988; 33: 660–6
   PubMed Web of Science ®Google Scholar
• Whittle B JR. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 1981; 80: 94–8
   PubMed Web of Science ®Google Scholar
• Erickson R A, Macias G, Rivera N. Mechanism of synergism of nitric oxide (NO) inhibition on intestinal injury by nabumetone and indomethacin. Gastroenterology 1994; 106: A125
   PubMed Web of Science ®Google Scholar
• Carfoli E. Intra cellular calcium homeostasis. Ann Rev Biochem 1987; 56: 395–433
   PubMedGoogle Scholar
• Haussinger D, Lang F. The mutual interactions between cell volume and cell function: a new principle of metabolic regulation. Biochem Cell Biol 1991; 69: 1–4
   PubMed Web of Science ®Google Scholar
• Madara J I, Dharmasthaphorn K. Occluding junction structure-function relationships in a cultured epithelial monolayer. J Cell Biol 1985; 101: 2124–33
   PubMed Web of Science ®Google Scholar
• Madara J L, Barenberg D, Carlson S. Effect of cytochalasin D on occluding junctions of intestinal absorptive cells: further evidence that the cytoskeleton may influence paracellular permeability and junctional charge selectivity. J Cell Biol 1986; 102: 2125–36
   PubMed Web of Science ®Google Scholar
• Madara J L, Barenberg D, Carlson S. The effects of cytochalasine D on occluding junctions of intestinal absorptive cells: further evidence that cytoskeleton may influence paracellular permeability and junctional activity. J Cell Biol 1986; 102: 2125–36
   PubMed Web of Science ®Google Scholar
• Madara J L, Pappenheimer J R. Structural basis for physiological regulation of paracellular pathways in intestinal epithelia. J Membr Biol 1987; 100: 149–64
   PubMed Web of Science ®Google Scholar
• Madara J L. Tight junction dynamics: is paracellular transport regulated?. Cell 1988; 53: 497–8
   PubMed Web of Science ®Google Scholar
• Madara J L, Nash S, Moore R, Atisook K. Structure and function of the intestinal epithelial barrier in health and disease. Monogr Pathol 1990; 31: 306–24
   Google Scholar
• Meza I, Ibarra G, Sabanero M, Martinez-Palomo A. Occluding junctions and cytoskeletal components in a cultured transporting epithelium. J Cell Biol 1980; 87: 746–54
   PubMed Web of Science ®Google Scholar
• Rhoads C A, Aw T Y. Glucose stimulates enterocyte hydroperoxide metabolism by increased supply of reduced nicotinamide adenine dinucleotide phosphate (NADPH). Gastroenterology 1994; 106: A265
   Web of Science ®Google Scholar
• Davenport H W. Physiological structure of the gastric mucosa. Handbook of physiology, C F Code. American Physiological Society, Washington, DC 1967; 11: 201–4
   Google Scholar
• Newsholme E A, Crabtree B, Newsholme P. Use of enzyme activities as indices of maximum rates of fuel utilisation. Ciba Foundation Symposium 1980; 73: 245–58
   Google Scholar
• Sabine J R. Lipids in cancer: a functional or fictional association?. Trends Biochem Sci 1983; 8: 234–6
   Web of Science ®Google Scholar
• Parsons D S, Boyd C AR. Transport across the intestinal wall. Hierarchies of function. Rev Cytol 1972; 32: 209–55
   PubMedGoogle Scholar
• Brasitus T A, Schachter D. Lipid dynamics and lipid protein interactions in rat enterocyte basolateral and microvillus membranes. Biochemistry 1990; 19: 2763–9
   Google Scholar
• Windmuller H G, Spaeth A E. Respiratory fuels and nitrogen metabolism in vivo in small intestine of fed rats. J Biol Chem 1980; 255: 107–12
   PubMed Web of Science ®Google Scholar
• Baker R D. Intestinal sugar transport: does Na+ gradient provide all the energy?. Am J Physiol 1986; 250: G448–54
   Google Scholar
• Wright E M, Turk E, Zabel B, Mundlos S, Dyer J. Molecular genetics of intestinal glucose transport. J Clin Invest 1991; 88: 1435–40
   PubMed Web of Science ®Google Scholar
• Cheesman C I. GLUT2 is the transporter for fructose across the rat intestine. Gastroenterology 1993; 105: 1050–6
   PubMed Web of Science ®Google Scholar
• Levin R J. Digestion and absorption of carbohydrates—from molecules and membranes to humans. Am J Clin Nutr 1994; 59: 690S–8S, Suppl
   Web of Science ®Google Scholar
• Jamal A, Kellett G L, Robertson J P. The effect of glucose on the activity of phosphofructokinase in the mucosa of rat intestine. Biochem J 1984; 218: 459–64
   PubMed Web of Science ®Google Scholar
• Wandell P L. Distribution of glutathione reductase and detection of glutathione-cystine transhydrogenase in rat tissues. Biochem Biophys Acta 1968; 159: 179–81
   PubMedGoogle Scholar
• Metzger J, Lauterburgh B H. Increased generation of glutathione-di-sulphide [GSSG] in reperfused ischemic liver: prevention of oxidant stress and functional improvement by allopurinol. Gastroenterology 1985; 88: 1678
   Web of Science ®Google Scholar
• Haliwell B, Gutteridge J MC. Oxygen toxicity: oxygen radicals, transition metals and diseases. Biochem J 1984; 219: 1–14
   PubMed Web of Science ®Google Scholar
• Windmuller H G, Spaeth A E. Identification of ketone bodies and glutamine as the major respiratory fuels in vivo for post absorptive rat small intestine. J Biol Chem 1978; 253: 69–76
   PubMed Web of Science ®Google Scholar
• Evered D F, Masola B. The oxidation of glutamine and glutamate in relation to anion transport in enterocyte mitochondria. Biochem J 1984; 218: 449–58
   PubMed Web of Science ®Google Scholar
• Sheperd D, Garland P B. ATP controlled acetoacetate and citrate synthesis by rat liver mitochondria oxidising palmitoylcarnitine and inhibition of citrate synthase by ATP. Biochem Biophys Acta 1966; 22: 89–93
   Google Scholar
• Nygard G, Anthony A, Piasecki C, Trevetnick M A, Hudson M, Dhillon A P, et al. Acute indomethacin-induced jejunal injury in the rat: early morphological and biochemical changes. Gastroenterology 1994; 106: 567–75
   PubMed Web of Science ®Google Scholar
• Anthony A, Dhillon A P, Nygard G, Hudson M, Piasecki C, Strung P, et al. Early histological features of small intestinal injury induced by indomethacin. Aliment Pharmacol Ther 1993; 7: 29–40
   PubMed Web of Science ®Google Scholar
• Somasundaram S, Macpherson A J, Hayllar J, Saratchandra P, Bjarnason I. Enterocyte mitochondrial damage due to NSAID in the rat. Gut 1992; 33(Suppl 1)S5
   Google Scholar
• Hayllar J, Somasundaram S, Sarathchandra O, Levi A J, Bjarnason I. Early cellular events in the pathogenesis of NSAID enteropathy in the rat. Gastroenterology 1991; 100(Suppl 1)A216
   Google Scholar
• Tyler D D. Respiratory enzyme systems of mitochondria. The mitochondria in health and disease. VCH Publishers, New York 1991; 269–351
   Google Scholar
• Spenny J G, Bhown M. Effect of prostaglandin acid on gastric mucosa. II. Mucosal ATP and phosphocreatinine content and salicyclic effects on mitochondrial metabolism. Gastroenterology 1977; 73: 995–9
   PubMedGoogle Scholar
• Glarborg-Jorgensen T, Weis-Fogh U S, Neilsen H H, Olsen H P. Salicylate- and aspirin-induced uncoupling of oxidative phosphorylation in mitochondria isolated from the mucosal membrane of the stomach. Scand J Lab Invest 1976; 36: 649–53
   PubMed Web of Science ®Google Scholar
• Kaesbekar D K. Effects of salicylate and related compounds in gastric HC1 secretion. Am J Physiol 1973; 225: 521–7
   PubMedGoogle Scholar
• Ohe K, Hayashi K, Shirakawa J, Yamada K, Kawasaki T, Miyoshi A. Aspirin and taurocholate-induced metabolic damage in mammalian gastric mucosa in vitro. Am J Physiol 1980; 239: G457–62
   Google Scholar
• Adams S S, Cobb R R. A possible basis for the anti-inflammatory activity of salicylates and other non-hormonal antirheumatic drugs. Nature 1958; 181: 773–4
   PubMed Web of Science ®Google Scholar
• Whithouse M W. Some biochemical and pharmacological properties of anti-inflammatory drugs. Fortschr Arzneimittelforsch 1965; 8: 321–9
   PubMedGoogle Scholar
• Jongab R L, Halperin M L, Brosnan J T. Quantitative analysis of amino acid oxidation and related gluconeogenesis in humans. Physiol Rev 1992; 72: 419–48
   PubMed Web of Science ®Google Scholar
• Banergee R K. Non-steroidal anti-inflammatory drugs inhibit gastric peroxidase activity. Biochem Biophys Acta 1990; 1034: 275–80
   PubMedGoogle Scholar
• Tuena De Gomes-Puyou T, Gavilanes M, Gomez-Puyou A, Eronster L. Control of activity states of heart mitochondrial ATPase. Role of the proton motive force and Ca2+. Biochem Biophys Acta 1980; 592: 396–405
   PubMedGoogle Scholar
• Gasbarrini A, Borle A B, Farghali H, Bender C, Francavilla A, Thiel D V. Effects of anoxia on intracellular ATP, Na+ Ca2+ Mg2+ and cytotoxicity in the rat hepatocytes. J Biol Chem 1992; 267: 6654–63
   PubMed Web of Science ®Google Scholar
• Mozsik G U. Direct inhibitory effects of adenosine monophosphates on Na+-K+ dependent ATPase prepared from human gastric mucosa. Eur J Pharmacol 1980; 9: 207–10
   Google Scholar
• Kretsinger R H. Evolution and function of calcium binding proteins. Int Rev Cyt 1976; 46: 323–93
   PubMedGoogle Scholar
• Jain S K, Shohet S B. Calcium potentiates the peroxidation of erythrocyte membrane lipids. Biochem Biophys Acta 1981; 642: 45–54
   Google Scholar
• Tada M, Kitchberger M A, Repke D I, Katz A M. The stimulation of calcium transport in cardiac sacroplasmic reticulum by adenosine 3′-5′. Monophosphate-dependent protein kinase. J Biol Chem 1974; 249: 61–74
   Web of Science ®Google Scholar
• Hayllar J, Somasundaram S, Sarathchandra P, Levi A J, Bjarnason I. Early cellular events in the pathogenesis of NSAID enteropathy in the rat. Gastroenterology 1991; 100: A216
   Google Scholar
• Rodgers J B, Strittmatter A E. Lipid protein interactions in the reconstitution of the microsomal reduced nicotinamide adenine dinucleotide-cytochrome b5 reductase system. J Biol Chem 1973; 248: 800–6
   PubMed Web of Science ®Google Scholar
• Rodgers J B, Strittmatter P. Evidence for random distribution and translational movement of cytochrome b5 in endoplasmic reticulum. J Biol Chem 1974; 249: 895–900
   PubMed Web of Science ®Google Scholar
• Carg M L, Keelan M, Wierzbicki A, Thomson A BR, Clandinin M T. Regional differences in lipid composition and incorporation of saturated and unsaturated fatty acids in microsomal membranes of rat small intestine. Can J Physiol Pharmacol 1988; 66: 794–800
   PubMed Web of Science ®Google Scholar
• Windmuller H G, Spaeth A E. Fat transport and lymph and plasma lipoprotein biosynthesis by isolated intestine. J Lipid Res 1972; 13: 92–105
   PubMed Web of Science ®Google Scholar
• Cooper R A. Abnormalities of cell membrane fluidity in the pathogenesis of disease. N Engl J Med 1977; 297: 371
   PubMed Web of Science ®Google Scholar
• Dudeja P K, Brasitus T A. Inactivation of rat small intestinal brush-border membrane alkaline phosphatase by oxygen free radicals. Gastroenterology 1993; 105: 357–66
   PubMed Web of Science ®Google Scholar
• Somasundaram S, Sadique J. The effect of peripheral inflammation and the action of antiinflammatories on the intestinal transport of 14C-leucine in rats. Acta Biol Med Exp 1985; 10: 35–9
   Google Scholar
• Kimberg D V, Field M, Johanson J, Gershon E. Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins. J Clin Invest 1971; 50: 1218–30
   PubMed Web of Science ®Google Scholar
• Gullikson G W, Cline W S, Lorenzson V, Benz L, Olsen W A, Bass P. Effects of anionic surfactants on hamster small intestinal membrane structure and function: relationship to surface activity. Gastroenterology 1977; 73: 501–11
   PubMed Web of Science ®Google Scholar
• Gullikson G W, Sender M, Bass P. Laxative-like effects of nonsteroidal anti-inflammatory drugs on intestinal fluid movement and membrane integrity. J Pharmacol Exp Ther 1981; 220: 236–52
   Web of Science ®Google Scholar
• Lichtenberger L M, Romero J J, Wang Z M. ASA forms an ionic complex with phosphatidylcholine: possible molecular explanation for its ulcerogenic action. Gastroenterology 1994; 106: A134
   PubMedGoogle Scholar
• Rask-Madsen J, Bukhave K, Laursen L S, Lauritsen K. Eicosanoids in inflammatory bowel disease—physiology and pathology. The cell biology of inflammation in the gastrointestinal tract, T J Peters. Corners Publication, Hull 1990; 255–71
   Google Scholar
• Wallace J L, Granger D N. Pathogenesis of NSAID gastropathy: are neutrophils the culprits?. Trends Pharmacol Sci 1992; 13: 129–30
   PubMed Web of Science ®Google Scholar
• Robert A. Cytoprotection by prostaglandins. Gastroenterology 1979; 77: 761–7
   PubMed Web of Science ®Google Scholar
• Levi S, Goodlad R A, Lee C Y. Inhibitory effect of non steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet 1990; 336: 840–3
   PubMed Web of Science ®Google Scholar
• Lewis G P. Immunoregulatory activity of metabolites of arachidonic acid and their role in inflammation. Br Med Bull 1983; 39: 243–8
   PubMed Web of Science ®Google Scholar
• Granger D N, Richardson P DI, Kvietys P R, Mortillario N A. Intestinal blood flow. Gastroenterology 1980; 78: 837–63
   PubMed Web of Science ®Google Scholar
• Cassidy M M, Lightfoot P G. Effects of prostaglandins E1 administered by gastric incubation on mucus secretory patterns in rat small intestine. Adv Prostagland Thrombox Res 1980; 8: 1589–1593
   PubMedGoogle Scholar
• Bikhazi A B, Nadir S N, Hajjar J J. Calcium-prostaglandin aggregation and fits effect on prostaglandin uptake by isolated rabbit intestine. J Pharmaceut Sci 1977; 66: 1308–12
   PubMed Web of Science ®Google Scholar
• Meade E A, Smith W L, DeWitt D L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993; 268: 6610–4
   PubMed Web of Science ®Google Scholar
• Wallace J L, Keenan C M, Gale D, Schoupe T S. Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis. Gastroenterology 1992; 102: 18–27
   PubMed Web of Science ®Google Scholar
• Wallace J L, Whittle B JR. Gastrointestinal damage induced by platelet activating factor. Inhibition by the corticoid dexa-methasone. Dig Dis Sci 1988; 33: 225–32
   PubMed Web of Science ®Google Scholar
• Wallace J L, Whittle B JR. Picomole doses of platelet activating factor predisposes the gastric mucosa to damage by topical irritants. Prostaglandins 1986; 31: 989–98
   PubMed Web of Science ®Google Scholar
• Whittle B JR, Kaufman G L, Moncada S. Vasoconstriction with thromboxane A2 induces ulceration of gastric mucosa. Nature 1981; 292: 472–4
   PubMed Web of Science ®Google Scholar
• Rosam A C, Wallace J L, Whittle B JR. Potent ulcerogenic action of platelet-activating factor on the stomach. Nature 1986; 319: 54–6
   PubMed Web of Science ®Google Scholar
• Pihan G, Majzoubi D, Haudenschild C TJ, Szabo S. Early microcirculatory stasis in acute gastric mucosal injury in the rat and prevention by 16, 16-dimethyl prostaglandin E2 or sodium thiosulfate. Gastroenterology 1986; 91: 1415–26
   PubMed Web of Science ®Google Scholar
• Robert A, Nezamis J E, Lancaster C, Hanchar A J. Cytoprotection by prostaglandins in rats—prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCI and thermal injury. Gastroenterology 1979; 77: 433–43
   PubMed Web of Science ®Google Scholar
• Miller T A. Protective effects of prostaglandins against gastric mucosal damage: Current knowledge and proposed mechanisms. Am J Physiol 1983; 245: G601–23
   PubMed Web of Science ®Google Scholar
• Morris G P, Williamson T E, Hynna T T. Prostaglandins and mucosal defensive mechanisms. Can J Gastroenterol 1990; 4: 95–107
   Google Scholar
• Guth P H, Paulsen G, Nagata H. Histology and micro-circulatory changes in alcohol-induced gastric lesions in the rat. Effect of prostaglandin cytoprotection. Gastroenterology 1984; 87: 1083–90
   PubMed Web of Science ®Google Scholar
• Hayllar J, Somasundaram S, Sarathchandra P, Levi A J, Bjarnason I. The effect of synthetic prostaglandins, a glucose and citrate formulation of indomethacin and other agents in preventing NSAID enteropathy in the rat. Gastroenterology 1991; 100(Suppl 1)A586
   Google Scholar
• Rainsford K, Dieppe P, Pritchard M H, Rhodes J, Leach H, Russell R E, et al. Protection from gastrointestinal side-effects by azopropazone by its incorporation into a glucose-sodium acid citrate formulation. Aliment Pharmacol Ther 1991; 5: 419–33
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Smethurst P, Macpherson A, Walker F, McLlnay S C, Passmure A P, et al. Glucose and citrate reduce the permeability changes caused by indomethacin in humans. Gastroenterology 1992; 102: 1546–50
   PubMed Web of Science ®Google Scholar
• Davin J C, Forget P, Mahieu P R. Increased intestinal permeability to (51Cr)EDTA is correlated with IgA immune complex-plasma levels in children with IgA-associated nephropathies. Acta Pediatr Scand 1988; 77: 118–24
   PubMed Web of Science ®Google Scholar
• Ferry D M, Butt T J, Broom M F, Hunter J, Chadwick V S. Bacterial chemotactic oligopeptides and the intestinal mucosal barrier. Gastroenterology 1989; 97: 61–7
   PubMed Web of Science ®Google Scholar
• Ramage J K, Stanisz A, Scicchitano R, Hunt R H, Perdue M H. Effects of immunologic reactions on rat intestinal epithelium. Correlation of increased intestinal permeability to chromium 51 labelled ethylenediaminetetraacetic acid and ovalbumin during acute inflammation and anaphylaxis. Gastroenterology 1988; 94: 1368–75
   PubMed Web of Science ®Google Scholar
• Teahon K, Webster A D, Price A B, Weston J, Bjarnason I. Studies on the enteropathy associated with primary hypogammaglobulinaemia. Gut 1994; 35: 1244–9
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Macpherson A JS, Somasundaram S, Teahon K. Non-steroidal anti-inflammatory drugs and Crohn's disease. Inflammatory bowel diseases: pathophysiology as basis of treatment, J Scholmeric, W Kruis, H Goebbell, W Hohenberger, V Gross. Falk Symposium No 67, Kluwer Academic Publishers, Lancaster 1993; 208–22
   Google Scholar
• Bjarnason I, Macpherson A, Somasundaram S, Teahon K. Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease. Can J Gastroenterol 1993; 7: 160–9
   Google Scholar
• Aabakken L, Osnes M. 51 Cr-ethylenediaminetetraacetic acid absorption test. Effects of naproxen, a non-steroidal, antiinflammatory drug. Scand J Gastroenterol 1990; 25: 917–24
   PubMed Web of Science ®Google Scholar
• Aabakken L. 51 Cr ethylenediaminetetraacetic acid absorption test. Methodological aspects. Scand J Gastroenterol 1989; 24: 351–8
   PubMed Web of Science ®Google Scholar
• Aabakken L, Larsen S, Osnes K. Sucralfate for prevention of naproxen-induced mucosal lesions. Scand J Rheumatol 1989; 18: 361–8
   PubMed Web of Science ®Google Scholar
• Aabakken L, Larsen S, Osnes K. Cimetidine tablets or suspension in the prevention of gastrointestinal mucosal lesions caused by nonsteroidal anti-inflammatory drugs. Scand J Rheumatol 1989; 18: 647–55
   Web of Science ®Google Scholar
• Davies G R, Rampton D S. The pro-drug sulindac may reduce the risk of intestinal damage associated with the use of conventional non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 1991; 5: 593–8
   PubMed Web of Science ®Google Scholar
• Davies G R, Wilkie M E, Rampton D S. Effects of metronidazole and misoprostol on indomethacin-induced changes in intestinal permeability. Dig Dis Sci 1993; 38: 417–25
   PubMed Web of Science ®Google Scholar
• Jenkins R T, Rooney P J, Jones D B, Bienenstock J, Goodacre R L. Increased intestinal permeability in patients with rheumatoid arthritis. A side effect of nonsteroidal antiinflammatory drug therapy. Br J Rheumatol 1987; 26: 103–7
   PubMedGoogle Scholar
• Bjarnason I, Smethurst P, Fenn G C, Lee C F, Menzies I S, Levi A J. Misoprostol reduces indomethacin induced changes in human small intestinal permeability. Dig Dis Sci 1989; 34: 407–11
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Smethurst P, Clarke P, Menzies I S, Levi A J, Peters T J. Effect of prostaglandins on indomethacin induced increased intestinal permeability in man. Scand J Gastroenterol 1989; 29(Suppl 164)97–103
   Google Scholar
• Bjarnason I, Fehilly B, Smethurst P, Menzies I S, Levi A J. The importance of local versus systemic effects of non-steroidal anti-inflammatory drugs to increase intestinal permeability in man. Gut 1991; 32: 275–7
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Smethurst P, Menzies I S, Peters T J. The effect of polyacrylic acid polymers (carbopol) on small intestinal function and permeability changes caused by indomethacin. Scand J Gastroenterol 1991; 26: 685–8
   PubMed Web of Science ®Google Scholar
• Rooney P J, Jenkins R T. Nonsteroidal antiinflammatory drugs (NSAIDs) and the bowel mucosa. Changes in intestinal permeability may not be due to changes in prostaglandins. Clin Exp Rheum 1990; 8: 328–9
   PubMed Web of Science ®Google Scholar
• Duggan D E, Hooke K F, Noll R M, Kwan C K. Enterohepatic circulation of indomethacin and its role in intestinal irritation. Biochem Pharmacol 1975; 25: 1749–54
   Web of Science ®Google Scholar
• Bjarnason I, Smethurst P, Levi A J, Price A B. Indomethacin induced small intestinal ulceration in the rat. Gastroenterology 1988; 94(Suppl 1)A37
   Google Scholar
• Wilkinson P C. Leucocyte locomotion: determinants of locomotor capacity, chemotaxis and chemokinesis. The cell biology of inflammation in the gastrointestinal tract, T J Peters. Corners Publications, Hull 1990; 15–27
   Google Scholar
• Weiss G J. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365–76
   PubMed Web of Science ®Google Scholar
• Haslett C. Resolution and persistence of inflammation. The cell biology of inflammation in the gastrointestinal tract, T J Peters. Corners Publications, Hull 1990; 99–111
   Google Scholar
• Keshav S, Gordon S. Macrophage function in the gastrointestinal tract. The cell biology of inflammation in the gastrointestinal tract, T J Peters. Corners Publication, Hull 1990; 75–97
   Google Scholar
• Malech M I, Callin J I. Neutrophils in human disease. N Engl J Med 1987; 317: 687–94
   PubMed Web of Science ®Google Scholar
• Adams D H, Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 1994; 343: 831–6
   PubMed Web of Science ®Google Scholar
• Ouagliarello V, Scheld W. Bacterial meningitis: pathogenesis, pathophysiology, and progress. N Engl J Med 1992; 327: 864–72
   PubMed Web of Science ®Google Scholar
• Springer T A. Adhesion receptors of the immune system. Nature 1990; 346: 425–34
   PubMed Web of Science ®Google Scholar
• Wallace J L, Arfors K E, McKnight G W. A monoclonal antibody against the CD 18 leucocyte adhesion molecule prevents indomethacin-induced gastric damage in the rabbit. Gastroenterology 1991; 100: 878–83
   PubMed Web of Science ®Google Scholar
• Wallace J L, Keenan C M, Granger D N. Gastric ulceration induced by nonsteroidal antiinflammatory drugs is a neutrophil dependent process. Am J Physiol 1990; 259: G462–567
   PubMed Web of Science ®Google Scholar
• Segal A W. The electron transport chain of the microbial oxidase of phagocytic cells and its involvement in the molecular pathology of chronic granulomatous disease. J Clin Invest 1989; 83: 1785–93
   PubMed Web of Science ®Google Scholar
• Babior B M. The respiratory burst oxidase. Trends Biochem Soc 1987; 12: 241–3
   Web of Science ®Google Scholar
• Bagglioni M, Wyman M P. Timing of the respiratory burst. Trends Biochem Sci 1990; 15: 69–72
   PubMed Web of Science ®Google Scholar
• Bellavite P. The superoxide-forming system of phagocytes. Free Rad Biol Med 1988; 4: 225–61
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Hayllar J, Smethurst P, Price A B, Menzies I S, Gumpel M J. Metronidazole reduces inflammation and blood loss in NSAID enteropathy. Gut 1992; 33: 1204–8
   PubMed Web of Science ®Google Scholar
• Teahon K, Bjarnason I. Comparison of leukocyte excretion and blood loss in inflammatory disease of the bowel. Gut 1993; 34: 1535–8
   PubMed Web of Science ®Google Scholar
• Hayllar J, Price A B, Smith T, Macpherson A, Gumpel M J, Bjarnason I. Nonsteroidal antiinflammatory drug-induced small intestinal inflammation and blood loss: effect of sulphasalazine and other disease modifying drugs. Arthr Rheum 1994, In press
   PubMedGoogle Scholar
• Moser R, Schleiffenbaum B, Groscurth P, Fehr J. Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J Clin Invest 1988; 83: 444–55
   Web of Science ®Google Scholar
• Lamers J MJ, Hilsmann W C. The effect of fructose on the stores of energy rich phosphate in rat jejunum in vivo. Biochem Biophys Acta 1973; 313: 1–8
   PubMed Web of Science ®Google Scholar